Organigram Holdings Inc. Releases February 2025 Financial Insights in Form 6-K Report

Here are the key insights extracted from the provided section of the financial report (Form 6-K) for Organigram Holdings Inc.:

1. Company Information:

• Name: Organigram Holdings Inc.
• Address: 145 King Street West, Suite 1400, Toronto, Ontario, Canada M5H 1J8.
• Commission File Number: 001-38885.

2. Filing Type:

• This document is a Form 6-K, which is a report by a foreign private issuer. It is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

3. Reporting Period:

• The report covers the month of February 2025.

4. Annual Report Filing Indicator:

• The company has indicated that it files annual reports under Form 40-F.

5. Exhibits Included:

• The document references several exhibits, which provide additional financial details and management analysis. These include:
• • 99.1: Management's Discussion and Analysis for the three months ended December 31, 2024.
  • 99.2: Condensed Consolidated Interim Unaudited Financial Statements for the three months ended December 31, 2024.
  • 99.3: Certification of Interim Filings by the Chief Executive Officer dated February 11, 2025.
  • 99.4: Certification of Interim Filings by the Chief Financial Officer dated February 11, 2025.
  • 99.5: News Release announcing results for the three months ended December 31, 2024 dated February 11, 2025.

6. Signature:

• The report has been signed by Greg Guyatt, the Chief Financial Officer, confirming that the information is accurate as per the requirements of the Securities Exchange Act of 1934.

7. Date of Filing:

• The document was signed and presumably filed on February 11, 2025.

This summary encapsulates the essential details of the filing, including company identification, filing purpose, reporting period, and key documents included as exhibits.